Sponsored by:

Nuclear Medicine: Page 29

F-18 fluoroestradiol tracer useful for diagnosing breast cancer
By Will Morton
F-18 fluoroestradiol PET/CT imaging could improve patient management in women with invasive lobular carcinoma breast cancer, according to a presentation Sunday morning at the RSNA 2021 meeting.
November 27, 2021
2021 11 28 22 03 3202 2021 11 28 Fes Pet Covington 20211128220138
Photon-counting CT scanner paces Siemens at RSNA 2021
By Brian Casey
A new photon-counting CT scanner called Naeotom Alpha is the main attraction at the RSNA 2021 booth of Siemens Healthineers this week. The company is also highlighting new product launches in MRI, conventional CT, software for women's health, and other modalities.
November 27, 2021
2021 11 28 20 00 6152 Siemens Rsna 2021 400
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Researchers will discuss in this Sunday session how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 23, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 23, 2021
FDG-PET/CT scans assessed for clinical utility in COVID-19
By Will Morton
Monday, November 29 | 9:30 a.m.-10:30 a.m. | SSNMMI03-4 | Room S402In this talk, researchers will present a study to determine imaging findings and the potential clinical utility of FDG-PET/CT in patients with laboratory-confirmed COVID-19. They suggest FDG-PET/CT scans could be helpful in predicting disease severity.
November 22, 2021
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Here, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 22, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 22, 2021
Is FDG uptake normal in patients after ascending aorta replacement?
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-16In this presentation, Dutch cardiovascular imaging specialists will discuss interpreting normal F-18 FDG uptake on PET/CT after patients undergo combined aortic valve and ascending aorta replacement.
November 22, 2021
New radiotracer promising for diagnosing infection in vivo
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-14In this session exploring new frontiers in PET radiopharmaceuticals, researchers from the University of California, San Francisco will present results from an ongoing trial of a new carbon-11-labeled radiotracer that targets bacterial infection.
November 22, 2021
PET tracer synthesized for imaging cholesterol metabolism
By Will Morton
Thursday, December 2 | 1:30 p.m.-2:30 p.m. | SSNMMI08-1 | Room N228In this presentation, researchers will report a breakthrough after 40 years in the development of a new PET radiotracer for imaging abnormal cholesterol metabolism due to high levels of adrenal aldosterone.
November 22, 2021
PET/MRI assesses ankylosing spondylitis treatment
By Will Morton
Thursday, December 2 | 9:30 a.m.-10:00 a.m. | SSNMMI07-4 | Room E450BF-18 sodium fluoride PET/MR imaging of osteoblastic activity in ankylosing spondylitis patients can assess the effects of anti-tumor necrosis factor therapy, according to German researchers presenting in this session.
November 22, 2021
Antioxidant agent shows promise in reducing DNA damage from radiation
By Will Morton
Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSNMMI05-2 | Room E353CIn this session on advances in radionuclide therapy, researchers will present work on the identification and development of an antioxidant agent that may reduce damage to DNA caused by ionizing radiation.
November 22, 2021
Previous Page
Page 29 of 440
Next Page